AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31684921
Drug: In-clinic physical
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-clinic physical therapy intervention including manual therapy, stretching, strengthening, and neuromuscular functional training.
Trial: 26059526
Drug: Desmopressin tablets
RxNorm normalized name: desmopressin Sublingual Tablet
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Desmopressin tablets for 6 months
Trial: 1763561
Drug: Misoprostol (MS)
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol (MS) therapy (400 micrograms bid)
Trial: 21385988
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg (active control)
Trial: 26920602
Drug: Interrupted novel
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interrupted novel oral anticoagulant (dabigatran, rivaroxaban, or apixaban)
Trial: 17403578
Drug: Intradermal injection
RxNorm normalized name: Dryvax Intradermal Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal injection of ET-1 (concentrations ranging from 10(‐10) to 10(‐6)M)
Trial: 17197012
Drug: Intravaginal radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal radiation therapy (IVRT)
Trial: 30181338
Drug: Intramuscular oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular oxytocin (10 IU in 1 mL)
Trial: 12920409
Drug: Rapid initial
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid initial dose escalation (RIDE) of up to 40 mg of oral olanzapine on days 1 and 2, up to 30 mg on days 3 and 4, and 5 to 20 mg thereafter
Trial: 9292632
Drug: No capsule
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No capsule administered on days 1 and 9
Trial: 6297363
Drug: Synthetic human
RxNorm normalized name: Synthetic human secretin
DrugBank: Secretin human (DB09532)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synthetic human beta‐EP by constant rate IV infusion
Trial: 17102001
Drug: Timolol alone
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol alone dosed twice daily
Trial: 28241356
Drug: Testosterone gel
RxNorm normalized name: Androgel 1.62% Metered Dose Pump Testosterone Gel
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone gel for 1 year
Trial: 14741172
Drug: Vaccine consisting
RxNorm normalized name: IMMUNOTHERAPEUTIC VACCINE CONSISTING OF (PAM)2-LYS-SER-SER-GLN-TYR-ILE-LYS-ALA-ASN-SER-LYS-PHE-ILE-GLY-ILE-THR-GLU-ALA-ALA-ALA-PHE-LEU-PRO-SER-ASP-PHE-PHE-PRO-SER-VAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine consisting of recombinant baculovirus-derived KSA formulated with monophosphoryl lipid A (MPL) in liposomes and emulsified in mineral oil
Trial: 14741172
Drug: Vaccine with
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine with co-administration of human recombinant GM-CSF (rGM-CSF)
Trial: 14741172
Drug: Vaccine without
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine without GM-CSF
Trial: 22324448
Drug: Synbiotic formulation
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synbiotic formulation
Trial: 24010771
Drug: Whole-brain irradiation
RxNorm normalized name: pork brain preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-brain irradiation (WBI) with concomitant chloroquine (CLQ) 150 mg for 4 weeks
Trial: 7986837
Drug: Conventional CT
RxNorm normalized name: CT-179
DrugBank: CT-179 (DB17114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional CT technique, CM volume 150 ml of Ultravist 300 (30 ml at a flow rate of 1.5 ml/s, remaining 120 ml at 0.5 ml/s)
Trial: 20862715
Drug: Intravenous Salvia
RxNorm normalized name: SALVIA OFFICINALIS
DrugBank: Sage (DB10982)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Salvia miltiorrhiza after surgery for 3 days
Trial: 29804469
Drug: Zinc Gluconate
RxNorm normalized name: Zinc Gluconate
DrugBank: Zinc gluconate (DB11248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc Gluconate 233 mg/day plus vitamin E 400 IU/day for 6 weeks
Trial: 3989142
Drug: PEG-modified ragweed
RxNorm normalized name: Co-ArgI-PEG modified human arginase I
DrugBank: Pegzilarginase (DB14780)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG-modified ragweed extract (10 weekly injections for group 1, 6 injections for group 2, followed by 10 injections before the second season)
Trial: 27182022
Drug: Overcoming Compassion
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Overcoming Compassion Fatigue Program (5 weekly 80-minute sessions)
Trial: 25145986
Drug: House dust
RxNorm normalized name: House dust
DrugBank: House dust (DB10345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: House dust mite sublingual immunotherapy (SLIT) with Dermatophagoides farinae extracts for 52 weeks, combined with standard pharmacotherapy.
Trial: 20110015
Drug: Both formulations
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both formulations (generic and branded)
Trial: 10419912
Drug: Omeprazole therapy
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole therapy
Trial: 11762805
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics (ciprofloxacin plus roxithromycin)
Trial: 29605753
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group 1 - midwifery intervention involving oral health education, screening and referrals to existing dental pathways
Trial: 20735290
Drug: Eltrombopag 100
RxNorm normalized name: eltrombopag 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltrombopag 100 mg
Trial: 14646710
Drug: Highly cross-linked
RxNorm normalized name: riboflavin 5'-phosphate
DrugBank: Flavin mononucleotide (DB03247)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highly cross-linked polyethylene (absorbed dose, 95 kGy)
Trial: 14646710
Drug: Conventional gamma
RxNorm normalized name: Gamma Cyclodextrin
DrugBank: Gamma cyclodextrin (DB19173)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional gamma irradiated polyethylene (absorbed dose, 25-40 kGy)
Trial: 1674677
Drug: Vecuronium (V)
DrugBank: Vecuronium (DB01339)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vecuronium (V) 0.1 mg.kg‐1
Trial: 9659700
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg Sulprostongel (Nalador)
Trial: 1743318
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone (400 mg pessary)
Trial: 31069442
Drug: Low baseline
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low baseline 25OHD < 25 nmol/L
Trial: 28990437
Drug: Injection volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection volume of 2250 µL
Trial: 12707157
Drug: Bupivacaine 6
RxNorm normalized name: BUPivacaine 660 MG in 5 mL Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 6 mg with saline (Control Group B)
Trial: 4684623
Drug: Marijuana cigarette
RxNorm normalized name: Picea mariana resin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marijuana cigarette containing less than 0.01 mg Delta(9)-THC
Trial: 4684623
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses of marijuana
Trial: 25240806
Drug: ICD therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICD therapy for women
Trial: 19148110
Drug: Intravenous digoxin
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous digoxin immune Fab (DIF)
Trial: 30971278
Drug: BCc1 nanomedicine
RxNorm normalized name: BCc1
DrugBank: BCc1 (DB16504)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCc1 nanomedicine (3000 mg for metastatic, 1500 mg for non-metastatic)
Trial: 27543500
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of calcium as citrate
Trial: 10710049
Drug: Intravenous (i.v.)
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (i.v.) pantoprazole (40 mg and 20 mg)
Trial: 11104314
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Comb) group (medicated)
Trial: 30002864
Drug: Subcutaneous golimumab
RxNorm normalized name: Golimumab
DrugBank: Golimumab (DB06674)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Subcutaneous golimumab
Trial: 17641254
Drug: Topiramate 50
RxNorm normalized name: topiramate 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate 50 mg/day
Trial: 23859414
Drug: Sauna treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sauna treatment
Trial: 21932426
Drug: Personalized peptide
RxNorm normalized name: peptide-T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personalized peptide vaccine (PPV)
Trial: 26114410
Drug: 13-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine
DrugBank: Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (DB10289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 13-valent pneumococcal conjugate vaccine (PCV)
Trial: 24046309
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg oseltamivir twice daily for 5 days
Trial: 29513931
Drug: AMG 557
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 557 210 mg
Trial: 30660342
Drug: Intravenous NSAIDs
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous NSAIDs
Trial: 16769748
Drug: Clomifene citrate
RxNorm normalized name: Clomifene citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomifene citrate plus metformin
Trial: 14581795
Drug: Glutamine-supplemented parenteral
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutamine-supplemented parenteral nutrition (n = 17)
Trial: 12182757
Drug: 50 micro
RxNorm normalized name: Digoxin 250 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 micro g octreotide
Trial: 24869609
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine infusion preoperatively and throughout surgery
Trial: 19606048
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (equal volume to morphine group)
Trial: 3541091
Drug: sobrerol 300
RxNorm normalized name: sobrerol
DrugBank: Sobrerol (DB13315)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sobrerol 300 mg b.i.d. for 3 months
Trial: 28509812
Drug: Ospemifene 60
RxNorm normalized name: ospemifene 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ospemifene 60 mg
Trial: 28289237
Drug: Dual-antiplatelet therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-antiplatelet therapy (clopidogrel-aspirin)
Trial: 30610279
Drug: R-CHOP plus
RxNorm normalized name: pantolactone, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-CHOP plus 8 doses of rituximab
Trial: 28926353
Drug: Lacosamide 800
RxNorm normalized name: Lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lacosamide 800 mg
Trial: 6509876
Drug: Extended phenytoin
RxNorm normalized name: Extended Phenytoin Sodium Capsules
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extended phenytoin sodium capsules
Trial: 15174791
Drug: Filtered infusions
RxNorm normalized name: FILTER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Filtered infusions via a central catheter
Trial: 29171818
Drug: Fremanezumab monthly
RxNorm normalized name: Fremanezumab
DrugBank: Fremanezumab (DB14041)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fremanezumab monthly (675 mg at baseline, 225 mg at weeks 4 and 8)
Trial: 30404123
Drug: Blind injections
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blind injections (palpation-guided)
Trial: 24135139
Drug: Essential amino
RxNorm normalized name: Essential amino acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Essential amino acids (EAAs) 20 g twice daily for 1 week before and 2 weeks after TKA
Trial: 10365809
Drug: High-dose ursodeoxycholic
RxNorm normalized name: ursodeoxycholate
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ursodeoxycholic acid (23-25 mg x kg(‐1) x day(‐1))
Trial: 22215918
Drug: Stimulus Control
RxNorm normalized name: Limulus polyphemus extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulus Control Therapy (SCT)
Trial: 16104447
Drug: Chest physical
RxNorm normalized name: Kids-Eeze Chest Relief
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chest physical therapy (CPT) after thoracoscopic surgery
Trial: 30552176
Drug: Lutikizumab 200
RxNorm normalized name: Lutikizumab
DrugBank: Lutikizumab (DB16224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutikizumab 200 mg subcutaneously every 2 weeks for 24 weeks
Trial: 3895410
Drug: Emepronium carrageenate
RxNorm normalized name: emepronium carrageenate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emepronium carrageenate (EC) 500 mg
Trial: 21783298
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of meloxicam IM
Trial: 1972557
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (800 micrograms)
Trial: 11293210
Drug: Intradermal vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal vaccination
Trial: 11865830
Drug: Pentoxifylline (PXF)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PXF) 1800 mg/day
Trial: 24602844
Drug: Early antiretroviral
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early antiretroviral treatment
Trial: 1452593
Drug: Distraction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distraction therapy using videos during burn dressing changes
Trial: 6711270
Drug: 40 ml
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 ml of 1% mepivacaine with adrenaline 1:200,000
Trial: 29855172
Drug: ABT-122 60
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-122 60 mg every other week
Trial: 7197091
Drug: Hormonal therapy
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal therapy (gestagen therapy)
Trial: 22634446
Drug: VLP immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VLP immunotherapy in Wenzhou
Trial: 19895362
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) with birch pollen allergen extract
Trial: 12749125
Drug: PGE1 cream
RxNorm normalized name: PGE1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PGE1 cream
Trial: 31086222
Drug: Iranian propolis
RxNorm normalized name: propolis
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iranian propolis (1000 mg/day)
Trial: 8542165
Drug: Budesonide 400
RxNorm normalized name: Budesonide 400 microgram/actuation powder for inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 400 micrograms three times daily
Trial: 20406154
Drug: Being driven
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Being driven to school daily
Trial: 19114261
Drug: Mindfulness meditation
RxNorm normalized name: benzalkonium chloride Topical Foam [Meditize]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness meditation combined with cognitive behavioral therapy for insomnia (CBT-I)
Trial: 25436803
Drug: Docetaxel alone
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel alone (75 mg/m intravenously, every 21 days)
Trial: 19681657
Drug: 36 g
RxNorm normalized name: ARBUTIN 0.36 g in 5 g CUTANEOUS LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 36 g alcohol daily
Trial: 7051813
Drug: Oral erythromycin
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral erythromycin therapy (for relapses)
Trial: 11316647
Drug: Tetracaine aerosol
RxNorm normalized name: Tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetracaine aerosol inhalation
Trial: 26585393
Drug: Problem-Solving Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem-Solving Therapy (PST) as add-on to standard outpatient rehabilitation
Trial: 10808701
Drug: 17 beta-estradiol
RxNorm normalized name: 17 beta-estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 beta-estradiol 2 mg and norethisterone acetate 1 mg
Trial: 12610862
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of new active agents (paclitaxel, gemcitabine, irinotecan)
Trial: 8740091
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (T) of N-desmethyl-tamoxifen
Trial: 22386829
Drug: Amlodipine 10
RxNorm normalized name: amlodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 10 mg (A)
Trial: 14973517
Drug: Enalapril 10
RxNorm normalized name: enalapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 10 mg/nitrendipine 20 mg (E/N)
Trial: 7943832
Drug: Propofol plus
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol plus fentanyl (1 ng/ml)
Trial: 7943832
Drug: Propofol plus
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol plus fentanyl (3 ng/ml)
Trial: 16413495
Drug: Cognitive therapy
RxNorm normalized name: cognitive therapy software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive therapy administered in small groups
Trial: 15498183
Drug: Metformin only
RxNorm normalized name: Metformin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin only (Group B)
Trial: 24176495
Drug: Late vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late vaccination (day 16 after chemotherapy)
Trial: 8287830
Drug: Anti-thyroid therapy
RxNorm normalized name: Thyroid
DrugBank: Thyroid, porcine (DB09100)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-thyroid therapy
Trial: 8287830
Drug: Propranolol 160
RxNorm normalized name: propranolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 160 mg/day for 28 days
Trial: 10460199
Drug: Nocturnal oral
RxNorm normalized name: Nocdurna Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nocturnal oral fat load test (OFLT) at 2200 h
Trial: 7791836
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (10-g intramuscular loading dose followed by 5 g every four hours; additional 4-g loading dose intravenously for severe preeclampsia)
Trial: 20560804
Drug: Occupational Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational Therapy (OT) program
Trial: 22006541
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg GS-9450
Trial: 25914483
Drug: Antibiotic group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic group (cefuroxime 1.5 g iv half an hour before and 6 h after surgery)
Trial: 7775727
Drug: 24 g
RxNorm normalized name: glucose 24 g/31 g oral gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24 g psyllium fiber daily for 1 month
Trial: 1499598
Drug: Moxonidine 0.2
RxNorm normalized name: moxonidine 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxonidine 0.2 mg non-fasting